doi:10.16150/j.1671-2870.2017.01.006

[1] Jain N, Roberts KG, Jabbour E, et al.Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults[J]. Blood,2017,129(5):572-581.
[2] Roberts KG, Gu Z, Payne-Turner D, et al.High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults[J]. J Clin Oncol,2017,35(4):394-401.
[3] Ge Z, Gu Y, Zhao G, et al.High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement[J]. Oncotarget,2016,7(31):49722-49732.
[4] Chen IM, Harvey RC, Mullighan CG, et al.Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study[J]. Blood,2012,119(15):3512-3522.
[5] Buitenkamp TD, Izraeli S, Zimmermann M, et al.Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group[J]. Blood,2014,123(1):70-77.
[6] Shochat C, Tal N, Gryshkova V, et al.Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia[J]. Blood,2014,124(1):106-110.
[7] Shochat C, Tal N, Bandapalli OR, et al.Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias[J]. J Exp Med,2011,208(5):901-908.
[8] Tal N, Shochat C, Geron I, et al.Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia[J]. Cell Mol Life Sci,2014,71(3):365-378.
[9] Roberts KG, Li Y, Payne-Turner D, et al.Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia[J]. N Engl J Med,2014,371(11):1005-1015.
[10] Tran TH, Loh ML.Ph-like acute lymphoblastic leukemia[J]. Hematology Am Soc Hematol Educ Program,2016, 2(1):561-566.
[11] Loh ML, Zhang J, Harvey RC, et al.Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project[J]. Blood,2013,121(3):485-488.
[12] Tasian SK, Teachey DT, Li Y, et al.Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia[J]. Blood,2017,129(2):177-187.
[13] Maude SL, Tasian SK, Vincent T, et al.Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia[J]. Blood,2012,120(17):3510-3518.
[14] Churchman ML, Mullighan CG.Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia[J]. Exp Hematol,2017, 46:1-8.
[15] Stadt UZ, Escherich G, Indenbirken D, et al.Rapid capture next-generation sequencing in clinical diagnostics of kinase pathway aberrations in B-cell precursor aLL[J]. Pediatr Blood Cancer,2016,63(7):1283-1286.
[16] Dörge P, Meissner B, Zimmermann M, et al.IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol[J]. Haematologica,2013,98(3):428-432.
[17] Yano M, Imamura T, Asai D, et al.Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion[J]. Br J Haematol,2015,171(5):813-817.
[18] Morak M, Attarbaschi A, Fischer S, et al.Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL[J]. Blood,2012,120(26):5134-5142.
[19] Zhao C, Khadka DB, Cho WJ.Insights into the structural features essential for JAK2 inhibition and selectivity[J]. Curr Med Chem,2016,23(13):1331-1355.
[20] Waibel M, Solomon VS, Knight DA, et al.Combined targeting of JAK2 and Bcl-2/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors[J]. Cell Rep,2013,5(4):1047-1059.
[21] Koppikar P, Bhagwat N, Kilpivaara O, et al.Hete-rodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy[J]. Nature,2012,489(7414):155-159.
[22] Sakamoto K, Imamura T, Kanayama T, et al. Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript[J/OL]. Genes Chromosomes Cancer,2016-11-07[2017-02-10].https://www.ncbi.nlm.nih.gov/pubmed/27870151.
[23] Marincevic-Zuniga Y, Zachariadis V, Cavelier L, et al.PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia[J]. Haematologica,2016,101(1):e20-e23.
[24] Louria-Hayon I, Frelin C, Ruston J, et al.Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling[J]. Proc Natl Acad Sci U S A,2013,110(51):20599-20604.
[25] Schwab C, Ryan SL, Chilton L, et al.EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications[J]. Blood,2016,127(18):2214-2218.
[26] Ishibashi T, Yaguchi A, Terada K, et al.Ph-like ALL-related novel fusion kinase ATF7IP-PDGFRB exhibits high sensitivity to tyrosine kinase inhibitors in murine cells[J]. Exp Hematol,2016,44(3):177-188.
[27] Kobayashi K, Miyagawa N, Mitsui K, et al.TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP/PDGFRB translocation[J]. Pediatr Blood Cancer,2015,62(6):1058-1060.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 14

Recommended Articles

Metrics

Comments

[1]	GAO Yanting, ZHAO Jinyan, WANG Juan, LI Jia, XU Wen, LI Li, LIN Lihui. Analysis of bone marrow lymphocyte subsets in patients with acute myeloid leukemia and its clinical significance [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 407-413.
[2]	PENG Zhenping, XIANG Xixi, ZHANG Sujiang, LI Jiaming. Chronic neutrophilic leukemia with leukemia-like reaction as the first-onset manifestation: a report of 2 cases and literature review [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 122-128.
[3]	. [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 585-587.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(06): 718-722.
[5]	ZHU Qingfeng, HU Xiaoli, ZHU Jianyi, LANG Wenjing, ZHONG Jihua, CHEN Fangyuan. Study on mechanism of synergistic effect of ASP2215 combined with SAHA on FLT3-ITD mutant cell line [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 538-546.
[6]	. [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(02): 211-215.
[7]	BAO Pingping, WU Chunxiao, ZHANG Minlu, GU Kai, XIANG Yongmei, PENG Peng, GONG Yangming, SHI Liang, ZOU Zhen.. Epidemiological features of major subtypes of leukemia and its incidence trends in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(05): 484-491.
[8]	WANG Shu, ZHANG Yunxiang, SUI Jingni, LU Jing, FAN Huiyong, WANG Chao, CHEN Bing.. Analysis of additional mutation pattern accompanied with CEBPA mutations in patients with the cytogenetically normal acute myeloid leukemia [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(05): 498-503.
[9]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 1-2.
[10]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 3-6.
[11]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 7-11.
[12]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 12-16.
[13]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 17-26.
[14]	ZHU Jianyi, LANG Wenjing, CHEN Fangyuan, XU Zhuoran, SHEN Lijing, ZHONG Jihua. Effect of arsenic trioxide on EVI1 gene in regulating hematopoietic transcription factors in vitro [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 42-47.